Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Y3 Biology Of Cancer > Week 8 > Flashcards

Week 8 Flashcards

You may prefer our related Brainscape-certified flashcards:
AP® Biology flashcards Biology 101 flashcards
1
Q

In general, why do melanomas arise?

A

Due to transformation of the melanocytes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are melanocytes and where are they found?

A

Melanin-producing cells found in the skin, eyes, mucous epithelia and meninges.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What controls the development of the melanocytes ?

A

The RTK c-KIT and the transcription factor MITF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What types of pigment do the melanocytes produce?

What colour are they?

A

Eumelanin (black/brown)

Pheomelanin (Red)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why may prediction and diagnosis of melanomas be tricky?

A

There are links to benign moles and sun exposure, but no reliable histological precursor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What % of global cancers are accounted for by melanomas?

A

1.7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How have mortality rates due to melanomas varied in the past years?

A

Mortality rates have fallen by 30% in the last decade.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How has incidence of melanoma changed in the past 30 years?

A

Increased by 140%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What % of skin cancers are melanomas?

A

4%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What % of skin cancer deaths are caused by melanomas?

A

80%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Outline some risk factors for melanoma.

A 
Sun exposure
Indoor tanning
Immunosuppression
Moles
Family history
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do the genotoxicity levels and exposure levels of UVA and UVB vary in terms of melanoma?

A

UVB is more genotoxic per photon than UVA. However, exposure to UVA is 30% higher.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How do UVB levels change throughout the day?

A

Fluctuate throughout the day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What type of cancer is caused by UVB?

A

Basal/ squamous cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe exposure to UVA

A

High and constant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What type of cancer does UVA cause?

A

Melanoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What components of indoor tanning cause melanomas?

A

UVA and UVB. Older sunbeds didn’t filter UVA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How does UVR affect the immune system? And how does this lead to tumour formation/ infiltration?

A
  • Apoptosis of keratinocytes triggers an innate immune response. This drives IFNy release from macrophages. This causes expression of immune evasion genes and enables tumour infiltration.
  • There are changes in the population of adaptive immune cells in the skin meaning that there is a reduction in cytotoxic T-cells but an increase in Treg cells which suppress inflammation.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the main genes found in families with melanoma?

A

CDK2NA and CDK4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Does UBV cause direct or indirect damage to the skin?

A

Direct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How does UBV damage the skin?

A

It directly damages the skin by producing cyclobutene pyramid dimers and pyrimidine-pyrimidine photoproducts.
These block transcription and translation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Does UVA cause direct or indirect DNA damage?

A

Indirect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How does UVA cause skin damage?

A

UVA causes indirect DNA damage via generation of reactive oxygen species. This lead to SSB/DSBs and 8oxoG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What can reduce UVA induced damage to skin cells?

A

Antioxidants

25
Q

What are nevi?

A

Benign moles recognised as direct precursors to melanomas.

26
Q

For people with over 100 moles, what is the level of their increased risk of developing melanoma compared with people who have more than 15 moles?

A

7 fold increase

27
Q

What are the advantages of using the ABCDE approach to grade melanoma?

A

Useful

Saved many lives

28
Q

What are the disadvantages of using the ABCDE approach to grade melanoma?

A

Around 60% clinical accuracy

29
Q

Name some methods for staging primary melanomas.

A

ABCDE
Clarks
Breslow
TNM

30
Q

What are the 2 stages of melanoma progression and what happens in each?

A

Stage 1 = Radial growth phase

Spreading within the epidermis

Stage 2 = Vertical growth phase

Invasion into the deeper dermis

Associated with metastasis

31
Q

What is the most common type of molecular mutation found in UVR induced melanomas?

A

C to T deamination

32
Q

What are the most common gene mutations found in melanomas?

A

BRAF(V600E)

NRAS

33
Q

What does the BRAF mutation do that eventually leads to melanoma?

A

Hyperactivation of the MAPK pathway

34
Q

What molecular modifications are often found when a person has melanoma?

A
  • Hyperactivation of the MAPK pathway
  • Amplification of AKT
  • Epigenetic
    silencing of PTEN
  • Amplified MIFT transcription factor causing it to become an oncogene
35
Q

What does the CDKN2 locus encode for?

A

2 tumour suppressor proteins:

  • P14(ARF) which regulates the P53 checkpoints
  • P16(INK4a) which regulates the Rb checkpoints
36
Q

How does lactate dehydrogenase act as a biomarker for melanoma?

A

Elevated levels in the blood correlate with poor survival in stage IV melanoma.

Lower levels = response to immunotherapy.

37
Q

What is the most clinically useful biomarker for melanoma?

A

Lactate dehydrogenase

38
Q

What is the most common type of treatment for melanoma?

A

Targeted therapies.

Specifically BRAF inhibitors - have great efficacy.

39
Q

What are the issues with targeted therapies used to treat melanomas?

A

There are issues with intrinsic and acquired resistance.

Paradoxal hyper activation of alternative MAPK pathways is also an issue.

40
Q

How can resistance of melanomas to therapies be predicted?

A

Can be predicted by assessing if tumours possess mutations in genes modulating apoptosis, proliferation etc.

E.g. loss of PTEN, activation of cyclin D1

41
Q

What mutations allow melanomas to be resistant to targeted therapies?

A

Usually via MEK1-activation mutations or RTK driver P13K activation.

42
Q

How is immunosuppression linked to melanoma?

A

Melanoma is more prevalent in immunosuppressed patients

43
Q

What are CAR-T cells and why are they unsuccessful in solid tumours?

A

Chimeric antigen receptor T cells.

  • Migration to the tumour site via vasculature
  • Immunosuppressive TME
  • Unsure of what CAR to use
44
Q

What was the first non-chemotherapeutic agent approved to treat melanoma and what were the issues with it?

A

High dose interleukin 2

  • Limited efficacy
  • High toxicity
45
Q

How do immune checkpoint inhibitors work against melanomas and why are they successful?

A

T cell activation required T-cell receptor recognition of an antigen of the surface of an antigen presenting cell and a costimulatory interaction between the T cell and APC.

The 2nd costimulatory step can be mediated by either stimulatory or inhibitors ligand pairs known as immune checkpoints.

46
Q

Outline how CTLA4 works as an immune checkpoint inhibitor against melanoma.

A

TLA4 is a negative regulator of T cell activation which blocks antibodies when bound to Fc receptor on antigen presenting cells.
This promotes antibody-dependant cellular cytotoxicity.
A-CTLA4 can bind to CTLA4 on the surface of the T regulatory cells and prevent them from counter-regulating the CD28-mediated co-stimulatory pathways that are playing a role in T cell activation.

A-CTLA4 can also promote T cell responses by blocking CTLA4 on the surface of conventional T cells as they undergo activation.

47
Q

What is the purpose of melanin in the body?

A

Skin pigmentation

48
Q

What are some possible results caused by mutations in. the MC1R melanin receptor?

A

Altered signalling and melanin production.

Some mutations within this receptor mean that no eumelanin is produced. This is often the case in individuals with red hair.

49
Q

What are the 3 types of UV radiation?

A

UVA
UVB
UVC

50
Q

Can UVC penetrate the epidermis?

A

No, it is blocked by the ozone layer.

51
Q

Can UVB penetrate the epidermis? If so, where up to ?

A

Yes, up to the desmosomes

52
Q

Can UVA penetrate the epidermis and if so, where up to?

A

UVA can penetrate the whole epidermis, up to the basal lamina.

53
Q

What is the main difference between the way UVA and UVB cause melanoma.

A

UVB causes direct DNA damage.

UVA causes indirect DNA damage.

54
Q

What does each of the categories in the ABDE screening system mean?

A 
A = Symmetry
B = Border
C = Colour
D = Diameter
E = Evolving
55
Q

Which progression stage of melanoma indicates metastasis?

A

Vertical growth phase - invasion deeper into the dermis which is associated with metastasis.

56
Q

Outline the effect of a mutation within the P14ARF tumour suppressor protein at the CDKN2A locus.

A

P14ARF which regulates the P53 checkpoints.

Regulates HDM2 which is a negative regulator of p53

P53 locked into inactive state

Cannot respond properly to DNA damage

DNA damage and genomic instability acrues

This allows melanocyte transformation to develop

57
Q

What affects the likelihood of an individual to develop resistance to a BRAF inhibitor ?

A

If PTEN is wild type, it is unlikely that you will develop resistance to the BRAF inhibitor. If it is wiltype, and is therefore mutated, the individual is likely to have resistance to BRAF inhibitors.

58
Q

How does the antibody drug against PD1 work? (Outline)

A

Antibody drug to prevent PD1 mediated de-acativation of activated T cells. Also, upregulated the T cell response against the tumour, killing the tumour.

Y3 Biology Of Cancer (8 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions